PAINS (Pan-Assay Interference Compounds)

Compounds that generate reactive oxygen species (ROS) in assay conditions, creating spurious activity signals.

• Mechanism: Cyclic oxidation-reduction under aerobic conditions produces hydrogen peroxide
• Common scaffolds: Quinones, catechols, and rhodanines
• Detection: Activity abolished by adding reducing agents like DTT or catalase
• Impact: These compounds appear active against diverse, unrelated targets including proteases, kinases, and GPCRs

Electrophilic warheads that form irreversible covalent bonds with nucleophilic protein residues, particularly cysteine thiols.

• Key substructures: Isothiazolones, maleimides, α,β-unsaturated carbonyls
• Behavior: Non-specific alkylation of multiple proteins creates pan-assay activity
• Red flag: Time-dependent inhibition that cannot be reversed by dialysis
• Counter-screen: Test for glutathione reactivity or use thiol-containing quenching agents

Molecules that sequester essential metal cofactors from metalloproteins, mimicking enzyme inhibition.

• Common motifs: Hydroxamic acids, 8-hydroxyquinolines, thiocarbazones
• Mechanism: Depletes Zn²⁺, Fe²⁺, or Mg²⁺ required for catalytic activity
• Deceptiveness: Activity disappears when excess metal ions are added to the assay buffer
• Example: Hydroxamic acid PAINS inhibit matrix metalloproteases and HDACs non-selectively

Small molecules that form dynamic colloidal particles (50-400 nm) in aqueous solution, non-specifically adsorbing and partially denaturing proteins.

• Detection: Inhibition reversed by non-ionic detergents like Triton X-100 or 0.01% BSA
• Physical property: Often flat, aromatic molecules with moderate logP
• Behavior: Steep, non-stoichiometric inhibition curves and sensitivity to enzyme concentration
• Prevalence: Estimated 1-3% of screening library compounds form aggregates at 30 µM

Compounds with intrinsic autofluorescence that overlap with common assay detection wavelengths, generating false signals.

• Problematic scaffolds: Furanones, pyrroles, and highly conjugated polyenes
• Impact: Artifacts in fluorescence polarization, FRET, and TR-FRET assays
• Detection: Measure compound fluorescence in assay buffer without protein target
• Wavelength ranges: Most problematic in blue-green channels (400-520 nm) used by fluorescein and GFP-based reporters

Computational substructure filters that flag PAINS before experimental screening.

• Baell & Holloway (2010): Original publication defining 480 PAINS substructures from AlphaScreen data
• Implementation: SMARTS pattern matching in tools like RDKit, KNIME, and Pipeline Pilot
• Limitations: Not all compounds matching a PAINS alert are problematic; context and concentration matter
• Evolution: Modern filters include ALARM NMR, FAF-Drugs4, and Lilly MedChem Rules for broader promiscuity detection

The physical-chemical processes by which PAINS produce false positive signals, independent of specific target binding.

• Covalent Protein Modification: Electrophilic warheads react irreversibly with cysteine or lysine residues
• Redox Cycling: Compound generates reactive oxygen species that activate reporter systems
• Colloidal Aggregation: Small molecules form 50-400 nm particles that non-specifically adsorb and inhibit proteins
• Metal Chelation: Compound strips essential cofactors from metalloenzymes
• Fluorescence Interference: Auto-fluorescent compounds overlap with assay detection wavelengths

Orthogonal experimental assays designed to confirm that a hit's activity is target-specific rather than an artifact of interference.

• Detergent addition: 0.01% Triton X-100 disrupts colloidal aggregates
• Reducing agent challenge: DTT addition quenches redox cyclers
• Enzyme concentration titration: True inhibitors show stoichiometric behavior; aggregators show non-stoichiometric inhibition
• Orthogonal assay format: Confirm activity using a different readout technology (e.g., SPR vs. fluorescence)
• ALARM NMR: Directly detects thiol-reactive compounds via NMR spectral changes